Market Tracker

04/26 5:16pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

31.28
Delayed Data
As of Apr 26
 +0.52 / +1.69%
Today’s Change
30.22
Today|||52-Week Range
56.91
-13.71%
Year-to-Date
Teva Confirms CFO Is Leaving
Apr 26 / TheStreet.com - Paid Partner Content
Will Fresenius' $4.75 Billion Deal for Highly Coveted Akorn Spark a Bidding War?
Apr 25 / TheStreet.com - Paid Partner Content
Meyer Handelman Co Buys Enbridge, Broadridge Financial Solutions, CDK Global, Sells S...
Apr 26 / GuruFocus News - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of April 14
Apr 22 / GuruFocus News - Paid Partner Content
Lesa Sroufe & Co Buys Banco Bilbao Vizcaya Argentaria SA, Teva Pharmaceutical Industr...
Apr 25 / GuruFocus News - Paid Partner Content
Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharm...
Apr 20 / GuruFocus News - Paid Partner Content
Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Apr 25 / TheStreet.com - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content
Teva Pharmaceutical CFO Stepping Down
Apr 25 / TheStreet.com - Paid Partner Content
Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug
Apr 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close30.76
Today’s open30.80
Day’s range30.80 - 31.67
Volume7,718,236
Average volume (3 months)9,058,329
Market cap$31.2B
Dividend yield4.35%
Data as of 4:01pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-6.41%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+12.01%
P/E ratio446.9
Price/Sales1.59
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.93+2.37%
OASMOasmia Pharmaceutica...+0.05+2.36%
Data as of 3:59pm ET, 04/26/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)$1.06
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts